Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Lal

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Lab on a Chip|August 29, 2025
Mechanical actuation on surface (MAOS) microfluidics: compression for preparation in next-generation sequencingParimala Nagaraja, Rohit Lal, Cheng-Chang Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrateEsther N Arwert, Rohit Lal, Sven Quist, et al.
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|May 20, 2026
Pose Guided Unsupervised Domain Adaptation for Human Body Part SegmentationArindam Dutta, Rohit Lal, Yash Garg, et al.
Future Oncology (London, England)|November 11, 2017
Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progressionGiuseppe L Banna, Ankur Sheel, Varun Sheel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesotheliomaLoïc Lang-Lazdunski, Andrea Bille, Rohit Lal, et al.
Anticancer Research|June 1, 2018
Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for ChemotherapyGiuseppe L Banna, Andrea Camerini, Giuseppe Bronte, et al.
Health and Quality of Life Outcomes|October 5, 2013
Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study designRohit Lal, Nawel Bourayou, Gunnar Hillerdal, et al.
Future Oncology (London, England)|July 7, 2018
Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practiceRaffaele Califano, Rohit Lal, Conrad Lewanski, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 3, 2015
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experienceLoïc Lang-Lazdunski, Andrea Bille, Sophie Papa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancerRohit Lal, James Dickson, David Cunningham, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Lab on a Chip|August 29, 2025
Mechanical actuation on surface (MAOS) microfluidics: compression for preparation in next-generation sequencingParimala Nagaraja, Rohit Lal, Cheng-Chang Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrateEsther N Arwert, Rohit Lal, Sven Quist, et al.
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|May 20, 2026
Pose Guided Unsupervised Domain Adaptation for Human Body Part SegmentationArindam Dutta, Rohit Lal, Yash Garg, et al.
Future Oncology (London, England)|November 11, 2017
Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progressionGiuseppe L Banna, Ankur Sheel, Varun Sheel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesotheliomaLoïc Lang-Lazdunski, Andrea Bille, Rohit Lal, et al.
Anticancer Research|June 1, 2018
Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for ChemotherapyGiuseppe L Banna, Andrea Camerini, Giuseppe Bronte, et al.
Health and Quality of Life Outcomes|October 5, 2013
Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study designRohit Lal, Nawel Bourayou, Gunnar Hillerdal, et al.
Future Oncology (London, England)|July 7, 2018
Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practiceRaffaele Califano, Rohit Lal, Conrad Lewanski, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 3, 2015
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experienceLoïc Lang-Lazdunski, Andrea Bille, Sophie Papa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancerRohit Lal, James Dickson, David Cunningham, et al.
Pageof 3